{
    "URL": "https://doi.org/10.1371/journal.pntd.0011138",
    "Published": "February 9, 2023",
    "Subject_Areas": [
        "Lesions",
        "Leishmaniasis",
        "Leprosy",
        "Drug therapy",
        "Nepal",
        "Kala-azar",
        "Medical risk factors",
        "Epidemiology"
    ],
    "Authors": {
        "Anand Ballabh Joshi": [
            "Public Health and Infectious Disease Research Center (PHIDReC), Kathmandu, Nepal"
        ],
        "Megha Raj Banjara": [
            "Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal",
            "WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland"
        ],
        "Murari Lal Das": [
            "Public Health and Infectious Disease Research Center (PHIDReC), Kathmandu, Nepal"
        ],
        "Pragyan Ghale": [
            "Public Health and Infectious Disease Research Center (PHIDReC), Kathmandu, Nepal"
        ],
        "Krishna Raj Pant": [
            "Public Health and Infectious Disease Research Center (PHIDReC), Kathmandu, Nepal"
        ],
        "Niraj Parajuli": [
            "Bir Hospital, Kathmandu, Nepal"
        ],
        "Uttam Raj Pyakurel": [
            "Epidemiology and Disease Control Division, Department of Health Services, Teku, Kathmandu, Nepal"
        ],
        "Gokarna Raj Dahal": [
            "Epidemiology and Disease Control Division, Department of Health Services, Teku, Kathmandu, Nepal"
        ],
        "Chuman Lal Das": [
            "Epidemiology and Disease Control Division, Department of Health Services, Teku, Kathmandu, Nepal"
        ],
        "Axel Kroeger": [
            "Centre for Medicine and Society, Albert-Ludwigs-University, Freiburg, Germany"
        ],
        "Abraham Aseffa": [
            "WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland"
        ]
    }
}